etomoxir has been researched along with labetalol in 1 studies
Studies (etomoxir) | Trials (etomoxir) | Recent Studies (post-2010) (etomoxir) | Studies (labetalol) | Trials (labetalol) | Recent Studies (post-2010) (labetalol) |
---|---|---|---|---|---|
260 | 8 | 93 | 1,980 | 450 | 327 |
Protein | Taxonomy | etomoxir (IC50) | labetalol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.016 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 3.354 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.01 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.8 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.393 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 3.354 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.521 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.393 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 3.037 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 1.607 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.815 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
1 other study(ies) available for etomoxir and labetalol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |